HCA Healthcare Inc. ($HCA) Stock Forecast: Up 2.7% Today

What is HCA Healthcare Inc.?

HCA Healthcare, Inc. (HCA):

Why is HCA Healthcare Inc. going up?

HCA stock is up 2.7% on Mar 12, 2026 14:41

• HCA Healthcare is a leading healthcare services provider in the US, offering a wide range of medical services to patients.
• The overall market sentiment for HCA Healthcare has been positive, with strong bullish movement today.
• Franklin Resources Inc. reducing its stake in HCA Healthcare did not hinder the company's performance, as it surpassed quarterly EPS expectations, raised its dividend, and received a "Moderate Buy" rating from analysts, leading to increased investor confidence.
• First Trust Advisors LP increasing its shares in HCA Healthcare suggests growing institutional interest, which has further bolstered market sentiment.
• The optimistic prospects for HCA Healthcare, coupled with the rise in quarterly dividend, likely contributed to the surge in the stock price today.

HCA Price Chart

HCA Technical Analysis

HCA News

HCA Healthcare, Inc. $HCA Position Lessened by Franklin Resources Inc.

Franklin Resources Inc. reduced its stake in HCA Healthcare by 17.8% in Q3 2025, selling over 250,000 shares. Despite this, HCA Healthcare recently beat quarterly EPS expectations, raised its dividend, and analysts generally maintain a "Moderate Buy" rating with an average price target of $537.73. Insiders have also been net sellers, divesting approximately $7.8 million worth of shares over the past 90 days.

https://www.marketbeat.com/instant-alerts/filing-hca-healthcare-inc-hca-position-lessened-by-franklin-resources-inc-2026-03-12/

Legal & General Group Plc Has $262.29 Million Position in ResMed Inc. $RMD

Legal & General Group Plc has reduced its stake in ResMed Inc. by 1.4%, now holding 958,210 shares valued at $262.29 million, representing about 0.66% of the company. ResMed recently reported strong quarterly earnings, beating estimates with an EPS of $2.81 and revenue of $1.42 billion, and declared a quarterly dividend of $0.60 per share, leading to analysts maintaining a "Moderate Buy" rating with an average price target of $299.27. Institutional investors own 54.98% of ResMed's stock, while insiders have recently sold shares.

https://www.marketbeat.com/instant-alerts/filing-legal-general-group-plc-has-26229-million-position-in-resmed-inc-rmd-2026-03-12/

First Trust Advisors LP Acquires 40,476 Shares of HCA Healthcare, Inc. $HCA

First Trust Advisors LP reported an increased stake in HCA Healthcare Inc. (NYSE:HCA), purchasing an additional 40,476 shares in Q3, bringing their total to 127,552 shares valued at $54.36 million. This move is part of a broader trend of institutional investors growing their positions in HCA. Analysts have issued predominantly "Buy" ratings for HCA Healthcare, with an average target price of $537.73, and the company recently announced an increase in its quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-first-trust-advisors-lp-acquires-40476-shares-of-hca-healthcare-inc-hca-2026-03-12/

Barclays PLC Sells 126,642 Shares of Tenet Healthcare Corporation $THC

Barclays PLC reduced its holdings in Tenet Healthcare Corporation by 49.2% in the third quarter, selling 126,642 shares and retaining 130,574 shares valued at $26.51 million. Despite this, other institutional investors have either increased their stakes or initiated new positions in the company. Analysts generally maintain a positive outlook on Tenet Healthcare, with a consensus "Moderate Buy" rating and an average target price of $247.67, following recent positive earnings and revenue reports.

https://www.marketbeat.com/instant-alerts/filing-barclays-plc-sells-126642-shares-of-tenet-healthcare-corporation-thc-2026-03-12/

Allianz, Sun Life Are Said to Weigh Bids for HSBC Life Singapore

Allianz SE and Sun Life Financial Inc. are reportedly considering bids for HSBC Holdings Plc’s insurance unit in Singapore, following HSBC's strategic review of the business. Japan's Dai-ichi Life Holdings Inc. and Nippon Life Insurance Co. might also enter the bidding. A sale process has begun, with non-binding bids expected in the coming weeks.

https://www.bloomberg.com/news/articles/2026-03-12/allianz-sun-life-are-said-to-weigh-bids-for-hsbc-life-singapore

Trending Today

FuelCell Energy ($FCEL) Stock Forecast: Down 5.0% Today

Plug Power Inc. ($PLUG) Stock Forecast: Down 5.1% Today

DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Down 6.0% Today

Ulta Beauty Inc. ($ULTA) Stock Forecast: Down 14.0% Today

SNDL Inc. ($SNDL) Stock Forecast: Down 5.6% Today

Amplitude Inc. ($AMPL) Stock Forecast: Down 5.3% Today

Freeport-McMoRan Inc. ($FCX) Stock Forecast: Down 5.3% Today

Intuitive Surgical Inc. ($ISRG) Stock Forecast: Down 4.7% Today

Capri Holdings Limited ($CPRI) Stock Forecast: Up 5.3% Today

Lemonda Inc. ($LMND) Stock Forecast: Up 5.2% Today

HCA Healthcare Inc. Price History

11.01.2026 - HCA Stock was up 5.0%

• The reduction in stake by Prospera Financial Services Inc. did not deter other institutional investors like Norges Bank and Viking Global Investors LP from increasing their positions in HCA, indicating confidence in the company's growth prospects.
• HCA's robust financial performance, beating EPS estimates, issuing optimistic guidance, and raising its dividend, likely contributed to the bullish movement in its stock price.
• The upcoming community meetings regarding HCA Mission Health System may have also generated positive sentiment among investors, showcasing transparency and accountability in the company's operations.
• HCA's strategic focus on expanding market presence, enhancing digital capabilities, and managing risks highlighted in its SEC 10-K report further solidifies investor confidence in the company's long-term sustainability and growth potential.

05.00.2026 - HCA Stock was up 1.7%

• HCA Healthcare's stock rallied steadily due to strong fundamentals, consistent guidance, and a focus on returning cash to shareholders, attracting investor attention away from tech giants.
• The reduction in stake by Gateway Investment Advisers LLC and an EVP could indicate profit-taking after strong Q3 earnings and price target upgrades, contributing to the stock's positive momentum.
• The adoption of advanced robotics for orthopedic surgeries at Marion County HCA Hospitals showcases HCA's commitment to innovation and improving patient outcomes, potentially boosting investor confidence in the company's growth prospects.
• Despite a lower P/E ratio compared to the broader market, investors remain cautious about HCA Healthcare's future earnings volatility or potential threats, reflecting a sense of uncertainty despite the positive market outlook.

16.05.2025 - HCA Stock was down 4.1%

• Despite a bullish stance from investors with significant capital, HCA Healthcare experienced a strong bearish movement in the stock market today.
• The discrepancy between the bullish options trading activity and the bearish stock movement could indicate a divergence in market sentiment and actual performance of the company.
• It is possible that external factors, such as broader market conditions or specific company-related news not mentioned in recent updates, contributed to the bearish movement in HCA's stock price today.

27.00.2026 - HCA Stock was up 6.5%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst projections and resulting in a bullish trend in its stock price.
• Investor enthusiasm was fueled by the company's announcement of a new $10 billion share repurchase plan and an uptick in the quarterly dividend.
• Despite a slight miss in revenue expectations for Q4, HCA Healthcare's focus on profitability, sustained EPS growth, and ambitious financial objectives for 2026 provided a favorable perspective for investors.
• Confidence in HCA Healthcare's performance and future prospects was bolstered by Markel Group Inc.'s increased stake and the overall positive sentiment from analysts and institutional investors.

27.00.2026 - HCA Stock was up 7.1%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
• Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
• Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
• The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

11.01.2026 - HCA Stock was up 6.6%

• Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
• The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
• The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

12.01.2026 - HCA Stock was up 5.7%

• A notable reduction in LSV Asset Management's stake in HCA Healthcare by 2.9% initially raised concerns but did not dampen market sentiment due to the company's robust financial performance.
• The increase in earnings estimates for HCA Healthcare by Zacks Research, along with a "Hold" rating, indicates rising confidence in the company's future prospects, contributing to the positive market movement.
• HCA's stock hitting a new 52-week high and receiving an "Outperform" rating from analysts reflects investors' optimism about its ongoing growth and profitability.
• Despite a slight decrease in the Q1 2026 EPS estimate and an insider share sale causing some negative sentiment, the overall positive news of strong earnings, dividend increase, and strategic expansion into outpatient services drove HCA's stock to new highs.

22.06.2025 - HCA Stock was down 0.6%

• The bearish movement in HCA stock today could be attributed to the lack of optimistic expectations for its upcoming Q2 earnings:
• Analysts are cautious about the potential for an earnings beat, as the company may not possess the right combination of key ingredients.
• Investors might be adjusting their positions in anticipation of underwhelming performance in key metrics for the quarter ended June 2025.
• The market sentiment seems to be influenced by the uncertainty surrounding HCA Healthcare's earnings growth prospects, leading to a downward pressure on the stock price.

12.02.2026 - HCA Stock was up 2.7%

• HCA Healthcare is a leading healthcare services provider in the US, offering a wide range of medical services to patients.
• The overall market sentiment for HCA Healthcare has been positive, with strong bullish movement today.
• Franklin Resources Inc. reducing its stake in HCA Healthcare did not hinder the company's performance, as it surpassed quarterly EPS expectations, raised its dividend, and received a "Moderate Buy" rating from analysts, leading to increased investor confidence.
• First Trust Advisors LP increasing its shares in HCA Healthcare suggests growing institutional interest, which has further bolstered market sentiment.
• The optimistic prospects for HCA Healthcare, coupled with the rise in quarterly dividend, likely contributed to the surge in the stock price today.

24.09.2025 - HCA Stock was up 2.4%

• HCA Healthcare (HCA) exceeded expectations in Q3 earnings and revenues, reflecting a strong performance during the last quarter.
• Analysts adjusted their forecasts for HCA Healthcare before the earnings announcement, expecting a rise in quarterly earnings per share.
• With a track record of outperforming the market over the past decade, HCA Healthcare has consistently delivered returns to its investors.
• Despite concerns about rising costs affecting Q3 earnings, the company's robust revenue growth has fueled a bullish trend in its stock.

24.10.2025 - HCA Stock was down 1.9%

• The bearish movement in HCA stock today could be due to concerns about increased competition and potential market share loss following Teladoc's aggressive acquisition strategy in the healthcare industry.
• Investors might be worried that Teladoc's expanding global footprint and growth across key segments could pose a threat to HCA's market position and profitability.
• The market might be reacting to the perceived long-term impact of Teladoc's strategic moves on HCA's business prospects, leading to a sell-off of HCA shares in today's trading session.